Hematopoietic stem cell (CD34D) uptake of superparamagnetic iron oxide is enhanced by but not dependent on a transfection agent

Cytotherapy

Volumn 15, Issue 3, 2013, Pages 384-390

  England, Timothy J ^a   Bath, Philip M W ^a   Abaei, Maryam ^b   Auer, Dorothee ^b   Jones, D Rhodri E ^c  

^a Stroke Trials Unit   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Endorem; Ferumoxide; MRI; Protamine sulfate

Indexed keywords

PROTAMINE SULFATE; SUPERPARAMAGNETIC IRON OXIDE;

ARTICLE; CELL DIFFERENTIATION; CELL LABELING; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; ELECTRON MICROSCOPY; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 84875416108     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2012.10.016     Document Type: Article

References (21)

1. Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease.NEngl J Med. 2001;344:710-9.
2. Mancardi G, Saccardi R. Autologous hematopoietic stem-cell transplantation in multiple sclerosis. Lancet Neurol. 2008;7: 626-36.
3. Pal R, Venkataramana NK, Bansal A, Balaraju S, Jan M, Chandra R, et al. Ex vivo-expanded autologous bone marrowderived mesenchymal stromal cells in human spinal cord injury/paraplegia: A pilot clinical study. Cytotherapy. 2009;11: 897-911.
4. Plewka M, Krzeminska-Pakula M, Lipiec P, Peruga JZ, Jezewski T, Kidawa M, et al. Effect of intracoronary injection of mononuclear bone marrow stem cells on left ventricular function in patients with acute myocardial infarction. Am J Cardiol. 2009;104:1336-42.
5. Kondziolka D, Steinberg GK, Wechsler L, Meltzer CC, Elder E, Gebel J, et al. Neurotransplantation for patients with subcortical motor stroke: A phase 2 randomized trial. J Neurosurg. 2005;103:38-45.
6. England TJ, Abaei M, Auer DP, Lowe J, Jones DR, Sare G, et al. Granulocyte-colony stimulating factor for mobilizing bone marrow stem cells in subacute stroke: The stem cell trial of recovery enhancement after stroke 2 randomized controlled trial. Stroke. 2012;43:405-11.
7. Daldrup-Link HE, Rudelius M, Oostendorp RA, Jacobs VR, Simon GH, Gooding C, et al. Comparison of iron oxide labeling properties of hematopoietic progenitor cells from umbilical cord blood and from peripheral blood for subsequent in vivo tracking in a xenotransplant mouse model XXX. Acad Radiol. 2005;12:502-10.
8. Daldrup-Link HE, Rudelius M, Oostendorp RA, Settles M, Piontek G, Metz S, et al. Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology. 2003;228:760-7.
9. Arbab AS, Yocum GT, Kalish H, Jordan EK, Anderson SA, Khakoo AY, et al. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood. 2004;104:1217-23.
10. Arbab AS, Yocum GT, Rad AM, Khakoo AY, Fellowes V, Read EJ, et al. Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells. NMR Biomed. 2005;18:553-9.
11. Jiang Q, Zhang ZG, Ding GL, Silver B, Zhang L, Meng H, et al. MRI detects white matter reorganization after neural progenitor cell treatment of stroke. Neuroimage. 2006;32: 1080-9.
12. Guzman R, Bliss T, De Los Angeles A, Moseley M, Palmer T, Steinberg G. Neural progenitor cells transplanted into the uninjured brain undergo targeted migration after stroke onset. J Neurosci Res. 2008;86:873-82.
13. Guzman R, Uchida N, Bliss TM, He D, Christopherson KK, Stellwagen D, et al. Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI. Proc Natl Acad Sci U S A. 2007;104: 10211-6.
14. Reimer P, Tombach B. Hepatic MRI with SPIO: Detection and characterization of focal liver lesions. Eur Radiol. 1998;8: 1198-204.
15. Bull BS, Huse WM, Brauer FS, Korpman RA. Heparin therapy during extracorporeal circulation, II: The use of a dose-response curve to individualize heparin and protamine dosage. J Thorac Cardiovasc Surg. 1975;69:685-9.
16. Akbari AA, Mozdarani H, Akhlaghpoor S, Pourfatollah AA, Soleimani M. Evaluation of the homing of human CD34? cells in mouse bone marrow using clinical MR imaging. Pak J Biol Sci. 2007;10:833-42.
17. Daldrup-Link HE, Rudelius M, Piontek G, Metz S, Brauer R, Debus G, et al. Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: In vivo monitoring with 1.5-T MR imaging equipment. Radiology. 2005;234:197-205.
18. Niemeyer M, Oostendorp RA, Kremer M, Hippauf S, Jacobs VR, Baurecht H, et al. Non-invasive tracking of human haemopoietic CD34(?) stem cells in vivo in immunodeficient mice by using magnetic resonance imaging. Eur Radiol. 2010; 20:2184-93.
19. Nohroudi K, Arnhold S, Berhorn T, Addicks K, Hoehn M, Himmelreich U. In vivo MRI stem cell tracking requires balancing of detection limit and cell viability. Cell Transplant. 2010;19:431-41.
20. Farrell E, Wielopolski P, Pavljasevic P, van Tiel S, Jahr H, Verhaar J, et al. Effects of iron oxide incorporation for long term cell tracking on MSC differentiation in vitro and in vivo. Biochem Biophys Res Commun. 2008;369:1076-81.
21. Janic B, Rad AM, Jordan EK, Iskander AS, Ali MM, Varma NR, et al. Optimization and validation of Fe-Pro cell labeling method. PLoS One. 2009;4:e5873.